• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铜和氯胺酮在重度抑郁症中的作用——最新研究进展。

Role of copper and ketamine in major depressive disorder - an update.

机构信息

Department of Psychiatry, Faculty of Medicine, Medical University of Gdansk, Dębinki St. 7 build. 25, 80-952 Gdańsk, Poland,

出版信息

Psychiatr Danub. 2019 Sep;31(Suppl 3):520-523.

PMID:31488784
Abstract

Major depressive disorder is one of the most important psychiatric issues worldwide, with important prevalence of treatment-resistant depression (TRD). Non-monoaminergic agents are currently in the spotlight. Objective was to explore for information about mechanisms of action of ketamine, its connections with copper and possible importance for TRD treatment. There are at least few possible pathways for ketamine action in depression in which copper and other divalent ions may show a vital role. There is urgent need for more studies to gather information about correlation between ketamine, copper and antidepressive features of these agents.

摘要

重度抑郁症是全球最重要的精神疾病之一,其中治疗抵抗性抑郁症(TRD)的患病率很高。目前非单胺能药物备受关注。目的是探讨氯胺酮的作用机制信息,及其与铜的联系和对 TRD 治疗的可能重要性。氯胺酮在抑郁症中的作用至少有几种可能的途径,其中铜和其他二价离子可能起着至关重要的作用。非常有必要进行更多的研究,以收集有关氯胺酮、铜和这些药物抗抑郁作用之间相关性的信息。

相似文献

1
Role of copper and ketamine in major depressive disorder - an update.铜和氯胺酮在重度抑郁症中的作用——最新研究进展。
Psychiatr Danub. 2019 Sep;31(Suppl 3):520-523.
2
Ketamine for Treatment-Resistant Depression: a New Advocate.氯胺酮用于治疗抵抗性抑郁症:一位新的支持者。
Rev Invest Clin. 2018;70(2):65-7. doi: 10.24875/RIC.18002501.
3
Copper and anti-anhedonic effect of ketamine in treatment-resistant depression.铜与氯胺酮在难治性抑郁症中的抗快感缺失作用
Med Hypotheses. 2020 Nov;144:110268. doi: 10.1016/j.mehy.2020.110268. Epub 2020 Sep 17.
4
Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects.抑郁症患者和健康对照者氯胺酮和安慰剂交叉试验的血浆代谢组学分析。
Psychopharmacology (Berl). 2018 Oct;235(10):3017-3030. doi: 10.1007/s00213-018-4992-7. Epub 2018 Aug 16.
5
Is Intravenous Ketamine Better Than Intranasal Esketamine for Treating Treatment-Resistant Depression?静脉注射氯胺酮治疗难治性抑郁症是否优于鼻内使用艾司氯胺酮?
Prim Care Companion CNS Disord. 2024 Feb 13;26(1):23lr03607. doi: 10.4088/PCC.23lr03607.
6
Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature.氯胺酮相关的脑改变:神经影像学文献综述。
Harv Rev Psychiatry. 2018 Nov/Dec;26(6):320-339. doi: 10.1097/HRP.0000000000000179.
7
Ketamine: Leading us into the future for development of antidepressants.氯胺酮:引领抗抑郁药研发的未来。
Behav Brain Res. 2020 Apr 6;383:112532. doi: 10.1016/j.bbr.2020.112532. Epub 2020 Feb 2.
8
Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?重新思考氯胺酮和 Esketamine 的作用:它们是具有稳定情绪作用的抗抑郁药吗?
Eur Neuropsychopharmacol. 2023 May;70:49-55. doi: 10.1016/j.euroneuro.2023.02.010. Epub 2023 Mar 1.
9
Ketamine for treatment-resistant depression: ready or not for clinical use?氯胺酮治疗难治性抑郁症:是否已准备好用于临床?
Am J Psychiatry. 2013 Oct;170(10):1079-81. doi: 10.1176/appi.ajp.2013.13081034.
10
Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder.治疗抵抗性重性抑郁障碍和双相障碍患者对氯胺酮反应的预测因素。
Int J Environ Res Public Health. 2018 Apr 17;15(4):771. doi: 10.3390/ijerph15040771.

引用本文的文献

1
Copper and Impulsivity in Ketamine Treatment for Treatment-Resistant Mood Disorders.氯胺酮治疗难治性情绪障碍中的铜与冲动性
Psychiatry Clin Psychopharmacol. 2021 Sep 1;31(3):353-357. doi: 10.5152/pcp.2021.21949. eCollection 2021 Sep.
2
Copper Concentrations in Ketamine Therapy for Treatment-Resistant Depression.氯胺酮疗法治疗难治性抑郁症中的铜浓度
Brain Sci. 2020 Dec 11;10(12):971. doi: 10.3390/brainsci10120971.